Woonsocket, Rhode Island-based CVS Health Corporation (CVS) offers a comprehensive range of healthcare solutions, including pharmacy benefit management services, mail-order pharmacies, retail ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded ...

CVS Health exceeded Q4 sales estimates with $97.71B revenue. ... Truist expects better operational performance, ... CVS stock is up 5.77% at $66.97 at the last check on Thursday.

CVS Health's issues didn't start in 2024, though, and that's the problem for the healthcare giant. It's much harder to ignore more than two years of poor performance. What exactly is going on with ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

This was the stock's second consecutive day of losses.

On Wednesday, CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total revenues increased 4.2%, driven by growth in the Health ...

CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock On Wednesday, CVS Health Corp (NYSE: CVS ) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 ...